- Home
- SLRN vs QSI Comparison
SLRN vs QSI Comparison
Compare SLRN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- QSI
- Stock Information
- Founded
- SLRN 2020
- QSI 2013
- Country
- SLRN United States
- QSI United States
- Employees
- SLRN N/A
- QSI N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- SLRN Health Care
- QSI Health Care
- Exchange
- SLRN Nasdaq
- QSI Nasdaq
- Market Cap
- SLRN 224.6M
- QSI 219.8M
- IPO Year
- SLRN 2023
- QSI N/A
- Fundamental
- Price
- SLRN $2.09
- QSI $1.46
- Analyst Decision
- SLRN Hold
- QSI Strong Buy
- Analyst Count
- SLRN 5
- QSI 3
- Target Price
- SLRN $9.60
- QSI $3.42
- AVG Volume (30 Days)
- SLRN 743.1K
- QSI 3.3M
- Earning Date
- SLRN 05-23-2025
- QSI 05-15-2025
- Dividend Yield
- SLRN N/A
- QSI N/A
- EPS Growth
- SLRN N/A
- QSI N/A
- EPS
- SLRN N/A
- QSI N/A
- Revenue
- SLRN N/A
- QSI $3,058,000.00
- Revenue This Year
- SLRN $267.11
- QSI $151.18
- Revenue Next Year
- SLRN N/A
- QSI $172.07
- P/E Ratio
- SLRN N/A
- QSI N/A
- Revenue Growth
- SLRN N/A
- QSI 182.63
- 52 Week Low
- SLRN $1.85
- QSI $0.61
- 52 Week High
- SLRN $7.25
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- SLRN 38.38
- QSI 61.14
- Support Level
- SLRN $2.34
- QSI $1.15
- Resistance Level
- SLRN $2.64
- QSI $1.35
- Average True Range (ATR)
- SLRN 0.19
- QSI 0.09
- MACD
- SLRN -0.01
- QSI 0.04
- Stochastic Oscillator
- SLRN 6.61
- QSI 74.23
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.